Four oral and five poster presentations demonstrate breadth and progress of AskBio’s gene therapy research, development, and ...

In a small valley in the Peloponnesus, the shrine of Asklepios, the god of medicine, developed out of a much earlier cult of Apollo (Maleatas), during the 6th century BC at the latest, as the official ...

MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 . MEDICLIN increases its consolidated sales for the first quarter of ...

Bayer and its subsidiary Asklepios BioPharmaceutical (AskBio) have reported data from an 18-month Phase Ib clinical trial of a gene therapy, AB-1005, aimed at treating Parkinson's disease (PD).

Annual ReportAsklepios Group: Asklepios shows resilience in 2023 financial year 25.04.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Asklepios Group: ...

The US Food and Drug Administration (FDA) has granted fast-track designation to Bayer subsidiary Asklepios BioPharmaceutical’s (AskBio) investigational gene therapy AB-1002, aimed at treating ...

US FDA grants Fast Track Designation to AskBio’s investigational gene therapy programme, AB-1002 in congestive heart failure: Berlin, Germany Friday, April 19, 2024, 09:00 Hrs [ ...

MEDICLIN ─ a company of the Asklepios Group 02.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content ...

The spine has a natural front-to-back curve. But about 2% of children and adolescents worldwide have an abnormal sideways S- ...

The Nomination files produced by the States Parties are published by the World Heritage Centre at its website and/or in working documents in order to ensure transparency, access to information and to ...

The Nomination files produced by the States Parties are published by the World Heritage Centre at its website and/or in working documents in order to ensure transparency, access to information and to ...